VERSANT VENTURE CAPITAL VI, L.P. sold 17.3% of their position (188.09K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market sale worth $7.42M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−20.49K
Price / share
$40.03
Trade value
$820.33K
% of position
Common Stock
Shares
−10.08K
Price / share
$40.03
Trade value
$403.34K
% of position
Common Stock
Shares
−5.67K
Price / share
$40.59
Trade value
$230.06K
% of position
Common Stock
Shares
−2.81K
Price / share
$40.59
Trade value
$114.02K
% of position
Common Stock
Shares
−50.27K
Price / share
$39.53
Trade value
$1.99M
% of position
Common Stock
Shares
−24.76K
Price / share
$39.53
Trade value
$978.65K
% of position
Common Stock
Shares
−2.15K
Price / share
$39.92
Trade value
$85.79K
% of position
Common Stock
Shares
−1.06K
Price / share
$39.92
Trade value
$42.24K
% of position
Common Stock
Shares
−43.98K
Price / share
$38.97
Trade value
$1.71M
% of position
Common Stock
Shares
−21.66K
Price / share
$38.97
Trade value
$844.22K
% of position
Common Stock
Shares
−3.46K
Price / share
$39.50
Trade value
$136.88K
% of position
Common Stock
Shares
−1.71K
Price / share
$39.50
Trade value
$67.43K
% of position
Net shares
−188.09K
Net value
-$7.42M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/22/2025 | S · Sale | −20.49K | $40.03 | $820.33K | 1.5% | 1.40M | 1.38M |
| Common Stock Indirect | 8/22/2025 | S · Sale | −10.08K | $40.03 | $403.34K | 1.0% | 962.88K | 952.80K |
| Common Stock Direct | 8/22/2025 | S · Sale | −5.67K | $40.59 | $230.06K | 0.4% | 1.38M | 1.37M |
| Common Stock Indirect | 8/22/2025 | S · Sale | −2.81K | $40.59 | $114.02K | 0.3% | 952.80K | 949.99K |
| Common Stock Direct | 8/25/2025 | S · Sale | −50.27K | $39.53 | $1.99M | 3.7% | 1.37M | 1.32M |
| Common Stock Indirect | 8/25/2025 | S · Sale | −24.76K | $39.53 | $978.65K | 2.6% | 949.99K | 925.23K |
| Common Stock Direct | 8/25/2025 | S · Sale | −2.15K | $39.92 | $85.79K | 0.2% | 1.32M | 1.32M |
| Common Stock Indirect | 8/25/2025 | S · Sale | −1.06K | $39.92 | $42.24K | 0.1% | 925.23K | 924.17K |
| Common Stock Direct | 8/26/2025 | S · Sale | −43.98K | $38.97 | $1.71M | 3.3% | 1.32M | 1.28M |
| Common Stock Indirect | 8/26/2025 | S · Sale | −21.66K | $38.97 | $844.22K | 2.3% | 924.17K | 902.51K |
| Common Stock Direct | 8/26/2025 | S · Sale | −3.46K | $39.50 | $136.88K | 0.3% | 1.28M | 1.27M |
| Common Stock Indirect | 8/26/2025 | S · Sale | −1.71K | $39.50 | $67.43K | 0.2% | 902.51K | 900.81K |
| Total | −188.09K | -$7.42M | ||||||
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 842.16K | Indirect |
| Total | 842.16K | 842.16K indirect |